NINGXIA ZHONGKE BIOTECHNOLOGY CO LT financial statements, including revenue, expenses, and profit
The total revenue of 600165 for the last quarter is 158.19 M CNY, and it's 129.67% higher compared to the previous quarter. The net income of Q4 24 is -59.37 M CNY.